myTomorrows

Home
myTomorrows

myTomorrows is an international platform that links patients facing unmet medical needs to treatments in development worldwide.

We bridge the gap between patients who are searching for treatment options and the pharmaceutical companies who provide them At myTomorrows, we believe everyone should be able to access the treatment options which are open to them. We strive to make it easier for physicians and their patients with unmet medical needs to find, get information about, and access pre-approval medicines whenever possible. We believe that by making the process of accessing pre-approval medicines more transparent, we’ll be able to transform the lives of people all over the world. To contact us, please visit https://www.mytomorrows.com/en/get-in-contact.

05/01/2026

BIO Partnering Week 2026 is just around the corner, and our team is looking forward to connecting with industry leaders, innovators, and investors from across the life sciences sector during this key healthcare investment event.

📅 January 12–15, 2026
📍 San Francisco, US

As the world's largest healthcare investment symposium, BIO Partnering Week brings together a broad range of stakeholders, including professionals from biotechnology and pharmaceutical research and development, investment sectors, digital therapeutics, government agencies, and patient advocacy organizations.

Our very own Dennis Akkaya, Chief Commercial Officer, and Stephanie Ferket, Director, Expanded Access Strategy & Customer Success at myTomorrows, will be attending to listen, learn, and engage in conversations around the latest developments across biotech and biopharma - from innovation and investment dynamics to evolving approaches in clinical development and patient access

💬 Interested in meeting Dennis and Stephanie during JPM Week?
👉 Book a meeting with them for thoughtful, industry-focused discussions: https://eu1.hubs.ly/H0qJ08n0

31/12/2025

Happy 2026 from myTomorrows! Here’s to a new year filled with health, progress, and meaningful moments. 🎉

💚 As we look back on the past year, we’re reminded that everything we do begins and ends with patient care. Whether that’s a patient reaching out for support in a time of need, exploring potential next steps, or trying to navigate a complex and unfamiliar treatment landscape. Our goal is to bring clarity and certainty to these moments through personalized support.

In 2025, we had the privilege of working alongside thousands of patients, families, physicians, and partners across the world. Together, we worked to reduce access barriers and bring greater transparency to the complex pre-approval landscape. ☀️

As we step into the new year, our focus remains clear: to continue to build innovative solutions that make the discovery and access to emerging therapies easier and more transparent. We believe that every patient deserves to know their options, and we are dedicated to making that a reality. 💪

Warm wishes from all our Mighties.

22/12/2025

As 2025 comes to a close, we’re reflecting on a year shaped by momentum, collaboration, and purposeful progress at myTomorrows. ✨

This year reinforced the power of working together. Through strong partnerships across the healthcare ecosystem, we continued to improve how patients and physicians navigate clinical trials and early access pathways with greater clarity and reach.

💡We also spent the year engaging in conversations with clinical experts and industry leaders around the world, exchanging perspectives on how access to emerging therapies can be improved across regions and healthcare systems.

Behind the scenes, we invested in innovation with intent, strengthening our platform and services to support smarter trial matching, more efficient access programs, and faster, more informed decision-making. That momentum was further supported by new growth investment, helping us accelerate what’s next. 💪

☀️ Above all, we’re grateful to the patients, families, healthcare professionals, and partners who shape our work every day.

We look ahead with focus and optimism, committed to a future where every patient can truly know their options. 💚

15/12/2025

🚨 New Whitepaper: Advancing Neuro-Oncology Clinical Trial Access Across Europe

Access to neuro-oncology clinical trials continues to vary widely across Europe – not due to lack of interest from patients or physicians, but as a result of fragmented workflows, inconsistent communication, and geographic disparities.

At this year’s EANO congress, myTomorrows hosted a roundtable with 10 leading neuro-oncology experts from the UK, Spain, Germany, Italy, the Netherlands, Austria, and Switzerland to discuss the systemic barriers that prevent patients from accessing clinical research opportunities.
The consensus? Solving these challenges requires better coordination, earlier information-sharing, and digital tools that bring sites, physicians and patients closer together.

In our latest whitepaper, we distill the insights from the roundtable:
🔹Where and why trial access breaks down
🔹How communication gaps limit timely enrollment
🔹 Operational and logistical hurdles.
🔹 Real-world solutions already emerging across Europe
🔹 Where digital innovation can make the biggest impact

If you work in neuro-oncology or clinical operations, this piece offers practical, peer-informed insights you can apply within your own network or trial site.

👉 Read the full paper here: https://eu1.hubs.ly/H0qpHt90

Special thanks to Prof. Susan Short, Prof. Maria Vieito Villar, Prof. Giuseppe Lombardi, Prof. Ghazaleh Tabatabai, Dr. Lukas Bunse, Dr. Emilie Le Rhun and Dr. Filip de Vos for their contributions to the roundtable.

-oncology

11/12/2025

The countdown to SCOPE US 2026 is officially on, and we’re excited to be back once again and contribute to the discussions! ⏳

📅 February 2–5
📍Orlando, US

Clinical trials remain essential to advancing healthcare: enabling researchers to study investigational treatments and offering patients with serious conditions, who have exhausted standard options, a path to access other possibilities when appropriate.

But bringing a trial from concept to completion requires far more than scientific rigor alone. It depends on collaboration, thoughtful innovation, and coordinated ex*****on across many teams and perspectives.

SCOPE US brings these stakeholders together under one roof, uniting clinical researchers, BioPharma leaders, patient advocates, and other professionals across the clinical trial ecosystem. Our team will be onsite to learn about the challenges they find navigating clinical trials and to share how myTomorrows supports key steps of the trial journey: from awareness and pre-screening to secure referrals and enrollment support.

🎤 We’ll also be presenting on patient recruitment and engagement on Wednesday, February 4, from 12:30–12:55 pm. We look forward to contributing to the discussion and hearing perspectives from others working to advance trial participation.

And throughout the event, you can find us at Booth #1417, where we’ll be glad to discuss:

✔️Approaches to easing recruitment and retention challenges
✔️Opportunities for collaboration across sites, BioPharma, and advocacy groups
✔️How AI-enabled tools can reduce manual burden for trial teams

Also attending SCOPE?
📩 Book a meeting with our team. We’d love to continue the conversation: https://eu1.hubs.ly/H0qlLJr0

10/12/2025

🎄 Secure your ticket before the holiday break!

The 2nd Pre-Approval Access to Medicines in Asia-Pacific Conference returns on 10–11 March 2026 in Singapore.
🔗 https://eu1.hubs.ly/H0qj9By0

The Asia-Pacific region is home to over 60% of the world’s population, yet hosts only 15–20% of global clinical trials and even fewer expanded access programs. Fragmented regulations, operational complexity, and resource constraints continue to limit timely pre-approval access for patients across APAC.

💡Last year’s inaugural conference created a long-awaited forum for industry, regulators, clinicians, and patient advocates to tackle these gaps together. As one participant shared:
“It was an extremely valuable conference. The patient group representatives added greatly to the discussion, which hasn’t always been the case at conferences.”

In 2026, we build on that momentum with a sharper focus on scalable, sustainable approaches for early access across APAC.

Key themes include
✔️Establish ethical principles to guide sustainable pre-approval access across APAC.
✔️Leverage pre-approval access as a strategic entry point for long-term APAC access.
✔️Assess regulatory maturity to enable scalable, sustainable access solutions.
✔️Strategies to reduce time-to-launch for medicines in APAC markets.
✔️Operational success factors for launching and scaling access programs.

If you work in biopharma, regulation, healthcare, research, or patient advocacy, this conference offers a unique opportunity to collaborate on overcoming regional barriers and accelerating patient access across the APAC region

🌏 Co-hosted by Novartis, Roche, BeOne Medicines, and the Asia Pacific Alliance of Rare Disease Organisations (APARDO), the 2026 edition brings together industry, clinical, and patient advocacy perspectives to move discussions beyond theory and into practical, region-ready solutions.

👉 Register here: https://eu1.hubs.ly/H0qj9By0

08/12/2025

What an energizing start to ASH 2025! 🎉

📍 Booth 273 has been busy

The conversations at our booth have been inspiring, and we’re enjoying meeting so many dedicated BioPharma partners, researchers, clinicians, and innovators from across the hematology community.

Here’s what the conversations at the booth have centered around:
✔️How to streamline Patient Recruitment
✔️ Approaches to designing and running Expanded Access Programs
✔️ Opportunities for BioPharma, trial sites, and physicians to collaborate on upcoming clinical research and access initiatives

💡Visitors are also showing strong interest in our AI-powered platform, particularly in how it helps simplify complex workflows across clinical trials and Expanded Access Programs. We’ve received many questions about its secure, compliant communication capabilities and about how the platform supports clear and confident patient data management.

👉 If you’re at ASH, we welcome you to visit us at Booth 273. We’d love to meet you and hear about your work. And if you’d like to make sure we don’t miss each other, you can still book time with our team: https://eu1.hubs.ly/H0qdGG20

See you at Booth 273! 👋

08/12/2025

Join our growing team! Become a part of our dynamic group of Mighties with diverse backgrounds in Medical, Pharma, Tech, and Business. This is an exciting opportunity to join our ambitious company as it grows.🚀

With benefits like flexible working, a learning and development budget, and an annual performance bonus, you’ll be based in Amsterdam with a fast-growing company of 80+ people, with 30 nationalities, helping patients to know all their treatment options. 💚

✔️DevOps Engineer: https://eu1.hubs.ly/H0qd8vW0
✔️Compliance Counsel: https://eu1.hubs.ly/H0qd7_s0
✔️Data & Reporting Analyst: https://eu1.hubs.ly/H0qd8WZ0

👉 Our full list: https://eu1.hubs.ly/H0qd7-x0

03/12/2025

We’re just days away from ASH 2025! ⏳

Thousands of hematology professionals will be gathering in Orlando to discuss the latest research and practice trends in hematology. As the countdown begins, our team is getting ready to join insightful conversation about how to advance hematology research, improve patient access, and support innovation across the field.

If you’re attending, we’d love to connect in person.

Where to find us
📍 Booth 273
📅 December 6–8, 2025
📌 Orlando, Florida

The myTomorrows team onsite:
🔹Nicola Laschi, Director of Pharma Partnerships
🔹Stephanie Ferket, Director, Expanded Access Strategy & Customer Success
🔹Michael Lambert, MBA, Senior Program Manager
🔹Adrianne Rivard, Senior Community Development Manager

What we’ll be sharing at our booth:
🔹How we support Patient Recruitment, from awareness and pre-screening to secure referrals and enrollment
🔹 Our Expanded Access Solutions, including guidance with design, ex*****on, and close-out
🔹A look at our AI-powered platform, showcasing how it can streamline patient pre-screening, stakeholder communication and EAP navigation.

👉 Prefer to schedule time in advance? Book a meeting here: https://eu1.hubs.ly/H0q7djK0

Safe travels to everyone heading to ASH. See you soon in Orlando!

02/12/2025

A few weeks ago, we announced that myTomorrows has raised €25M in growth capital with Avego Healthcare Capital. And so much has happened since then. 🎉

Soon after the announcement, our HQ filled with green and white balloons, and even a custom-made cake to mark the occasion. But more than anything, it was the energy and excitement of our Mighties that made the celebration truly special.

But the momentum didn’t stop there.
🔹 In the days that followed, the announcement was featured across hundreds of media outlets, reflecting strong recognition of this achievement.
🔹 We also received heartfelt congratulations from clients, partners, investors, and friends worldwide. These messages carried a common theme: confidence in our direction.

💚 Because milestones like this are about more than capital: they’re about trust.
Trust in our team. Trust in our solutions. And trust in the mission that drives us: to enable earlier, better, and more equitable access to emerging therapies through intelligent digital solutions and personalized, high-touch support.

To everyone who reached out over the past two weeks - and to every partner, physician, and patient who continues to trust us: thank you.

Your encouragement fuels our mission every day. And we’re just getting started.

👉 Read more about our story: https://eu1.hubs.ly/H0q5dHx0

Address

Website

https://myTomorrows.com/

Alerts

Be the first to know and let us send you an email when myTomorrows posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to myTomorrows:

Shortcuts

Want your practice to be the top-listed Clinic?

Country:

City:

05/01/2026

31/12/2025

22/12/2025

15/12/2025

11/12/2025

10/12/2025

08/12/2025

08/12/2025

03/12/2025

02/12/2025

Address

Website

Alerts

Contact The Practice

Shortcuts

Share